- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/705 - Récepteurs; Antigènes de surface cellulaire; Déterminants de surface cellulaire
Détention brevets de la classe C07K 14/705
Brevets de cette classe: 13273
Historique des publications depuis 10 ans
|
576
|
832
|
917
|
1148
|
1265
|
1351
|
1498
|
1450
|
1250
|
408
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4122 |
285 |
| The Regents of the University of California | 18943 |
262 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
176 |
| Immatics Biotechnologies GmbH | 1144 |
163 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
154 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
144 |
| Board of Regents, The University of Texas System | 5370 |
132 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
128 |
| Novartis AG | 11238 |
127 |
| Autolus Limited | 232 |
82 |
| The General Hospital Corporation | 4517 |
80 |
| City of Hope | 943 |
75 |
| CRISPR Therapeutics AG | 361 |
72 |
| Alpine Immune Sciences, Inc. | 77 |
68 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
65 |
| Baylor College of Medicine | 875 |
63 |
| Juno Therapeutics, Inc. | 365 |
63 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
62 |
| Genentech, Inc. | 3742 |
61 |
| Lentigen Technology, Inc. | 91 |
61 |
| Autres propriétaires | 10950 |